Modern diagnosis of early esophageal cancer: from blood biomarkers to advanced endoscopy and artificial intelligence

P Visaggi, B Barberio, M Ghisa, M Ribolsi, V Savarino… - Cancers, 2021 - mdpi.com
Simple Summary Esophageal cancer (EC) has a poor prognosis when the diagnosis is
delayed, but curative treatment is possible if the diagnosis is timely. The disease subtly …

Biomarkers for early detection, prognosis, and therapeutics of esophageal cancers

V Rai, J Abdo, DK Agrawal - International Journal of Molecular Sciences, 2023 - mdpi.com
Esophageal cancer (EC) is the deadliest cancer worldwide, with a 92% annual mortality rate
per incidence. Esophageal squamous cell carcinoma (ESCC) and esophageal …

[HTML][HTML] Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) guideline

BLAM Weusten, R Bisschops, M Dinis-Ribeiro… - …, 2023 - thieme-connect.com
MR1 ESGE recommends the following standards for Barrett esophagus (BE) surveillance:–a
minimum of 1-minute inspection time per cm of BE length during a surveillance endoscopy …

Epidemiology of Barrett's esophagus and esophageal adenocarcinoma: implications for screening and surveillance

MB Cook, AP Thrift - Gastrointestinal Endoscopy Clinics, 2021 - giendo.theclinics.com
Throughout the evolution of the definition of Barrett's esophagus (BE), the one thing that has
remained constant is the identification of some form of columnar epithelium on histologic …

Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression

KS Maslyonkina, AK Konyukova, DY Alexeeva… - Cancer …, 2022 - Wiley Online Library
Barrett's esophagus is a widespread chronically progressing disease of heterogeneous
nature. A life threatening complication of this condition is neoplastic transformation, which is …

Characterizing caspase-1 involvement during esophageal disease progression

G Barber, A Anand, K Oficjalska, JJ Phelan… - Cancer Immunology …, 2020 - Springer
Barrett's esophagus (BE) is an inflammatory condition and a neoplastic precursor to
esophageal adenocarcinoma (EAC). Inflammasome signaling, which contributes to acute …

[HTML][HTML] AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas

P Ghosh, VJ Campos, DT Vo, C Guccione… - JCI insight, 2022 - ncbi.nlm.nih.gov
Although Barrett's metaplasia of the esophagus (BE) is the only known precursor lesion to
esophageal adenocarcinomas (EACs), drivers of cellular transformation in BE remain …

Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett's esophagus

N Peleg, H Schmilovitz-Weiss, S Shamah… - …, 2021 - thieme-connect.com
Background Patient's with Barrett's esophagus (BE) are at risk of progression to esophageal
adenocarcinoma (EAC). Neutrophil to lymphocyte ratio (NLR) was found to be a predictor of …

Prognostic, diagnostic and predictive biomarkers in the Barrett's oesophagus-adenocarcinoma disease sequence

D O'Dowd, J O'Sullivan, S Marcone - Cancers, 2022 - mdpi.com
Simple Summary Oesophageal adenocarcinoma (OAC) is a type of cancer of the
oesophagus (food pipe) which is associated with poor patient outcomes. Barrett's …

Do immune inflammatory markers correlate with anal dysplasia and anal cancer risk in patients living with HIV?

J Stem, Q Yang, E Carchman, R Striker… - International Journal of …, 2022 - Springer
Purpose People living with HIV (PLWH) are at an elevated risk for developing anal cancer.
As screening is invasive, markers predicting those at highest risk for anal cancer could guide …